In Brief: Applied Medical v. U.S. Surgical
This article was originally published in The Gray Sheet
Executive SummaryApplied Medical v. U.S. Surgical: Damages of $20.5 mil. are awarded to Applied Medical Resources by a judge in the U.S. District Court of the Eastern District of Virginia for trocar patent infringement. USSC says it will establish a reserve for "the full amount of the award, plus related expenses," although the firm's appeal of the jury finding of infringement is still pending ("The Gray Sheet" May 19, In Brief)...
You may also be interested in...
TTS Pharma CEO Mark Tucker discusses his ambition to bring a legal CBD oil to the UK market, following the recent submission of a European Union novel food application.
Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch
The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.
Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.